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1. Introduction 
During the last decade, the characterization of Adult Stem Cells (ASC) incited 
extraordinary infatuation for the development of autologous cellular therapy. The number 
of directed cellular differentiation essays of hematopoietic and mesenchymal stem cells 
demonstrated, against the classical rules of embryology, unsuspected capacities to 
generate ex vivo practically all cellular types. Nevertheless, the difficulties of revealing 
these spectacular capacities during clinical applications of tissue reparation suggest a 
random evolution of cell cultures. The major influence on this reality may play 
fragmentary knowledge of transductional mechanisms controlling the cellular fate and 
above all, the quality of isolated cells. This last condition seems to represent the one of 
essential technical barriers. In fact, the process of cellular isolation principally residing in 
the employment of cellular adherence and/or magnetic field able to retain cells marked 
by tagged antibodies. Unfortunately, the proteins recognized by antibodies are not 
expressed by sole stem cells but also by committed progenitors. In fact, the bone marrow 
precursors represent very heterogenic population of mononuclear cells whose affiliation 
seemed to be recently questioned. For instance, the antibody against CD34 protein is 
employed for isolation of Hematopoietic Stem Cells (HSC) while the absence of CD45 
(universal hematopoietic cell marker) is recognized as sufficient to qualify Mesenchymal 
Stem Cells (MSC). Consequently, if previous observations revealed promising potential of 
bone marrow stem cells to be used for development of cellular therapy, their utilization 
must be preceded by detailed studies of their biology with particular focus on specific 
markers and transductional pathways permitting a high purity of isolation and control of 
differentiation protocols. The proposed chapter is based on our recent work indicating the 
heterogeneity of mesenchymal stem cells isolated from rabbit bone marrow which, placed 
in the context of recent studies, allows to propose a novel hierarchic organization of bone 
marrow cells. As ex vivo differentiation of stem cells would be dependent on 
transductional mechanisms we also propose to discuss how pharmacological modulation 
of activity of molecular target implicated in calcium homeostasis may influence cellular 
differentiation. 
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2. Heterogeneity of MSC 
2.1 Introduction 
Besides tissues having properties of self-renewal such bone marrow, the liver represents in 
Man the sole internal organ endowed with a spectacular capacity of regeneration illustrated 
already by the ancient myth of Prometheus. Interestingly, this process intervenes only after 
physical damage of the hepatic parenchyma which, destabilizing the entirety of the 
extracellular matrix, highlights the crucial role of epigenetic modulation on the proliferation 
and cellular differentiation (Michalopoulos & DeFrances, 1997; for review). Even if this 
natural phenomenon does not seem to be reproduced in internal organs, the recent isolation 
of adult multipotent, dormant within the various organs and tissues, stem cells seemed open 
the way towards a Regenerating Cellular Therapy. Indeed, the bibliographical data indicate 
a great plasticity of stem cells and in particular those taking from bone marrow like 
hematopoietic stem cells (HSC) and mesenchymal stem cells (MSC). Certain reports, already 
conclusive in the rat and the mouse, indicate a possibility of directed in situ and in vitro 
differentiation of stem cells and open exciting therapeutic prospects for tissue and various 
organs repair, without exposing the host to the failure of an allogeneic transplant rejection. 
Thus, contrary to embryonic stem cells (ESC) whose clinical application is still not 
unanimously accepted, ASC initially appeared as an ideal solution to prepare various 
autologous graft. Nevertheless, this dream about the imminent clinical application of ASC to 
cure a number of diseases as diabetes, cystic fibrosis, myocardial infarction and many others 
physiopathological states appeared more difficult to accomplish than initially expected. 
With the perspective of recent dynamic works it is conceivable to think that this is just a 
problem of a better knowledge of their diversity as well on the fundamental level as from 
the point of view of their therapeutic use.  
This observed ex vivo pluripotency of HSC and MSC was a cause of noted infatuation. 
Surprisingly, HSC known to date for their capacity of renewal of blood morphotical 
elements, were also able differentiated toward skeletal muscle (Ferrari, 1998), cardiac (Orlic 
et al., 2001), nervous (Mezey et al., 2000), liver (Lagasse et al., 2000) or epithelial cells 
(Krause et al., 2001). Despite the notable example of post infarct myocardium wall repair, 
these works did not open the way to the routine clinical application (Agbulut et al., 2004). 
Troublesome, these results appeared as not reproducible and the parabiosis experiments 
between exposed to radiation and green fluorescent protein (GFP)-transgenic mousses did 
not demonstrate this supposed regenerating power of HSC (Wagers et al., 2002).   
The ex vivo experiments carried out with MSC reporting relatively similar observations.  For 
a long time, MSC were considered as having potential of differentiation limited to 
mesenchymal family cells as osteoblasts, chondrocytes, adipocytes or muscle precursors 
(Ashton et al., 1980). More recently, MSC revealed in vitro abilities to generate cells 
distinguished also by ecto- and endodermal features (Reyes et al., 2002; Woodbury et al., 
2000; Sato et al., 2005). However, this pluripotentiality was objected by certain unsettled 
findings. At first, Hardeman et al. (1986) showed formation of cellular hybrids like 
myofibroblast which was forming by a fusion of fibroblasts with myoblastes able to 
conserve muscular character (Hardeman et al., 1986). Recently, the fusion of neuronal stem 
cells with ESC yielded cells expressing both characters (Ying et al., 2002). Since labeling 
technique with DNA coding enzymes or fluorescent proteins, these observations question 
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the reality of observed differentiation in situ. On the other hand, the possibility of phenotype 
modification of gene expression according to culture conditions could contribute to 
observed in vitro differentiation (Discher et al., 2009). It is also plausible that these divergent 
observations reflect a greate heterogeneity of MSC characterized by a certain ability of 
multipotency revealed during ex vivo manipulation where large majority of them represent 
committed progenitor cells rather than really pluripotent stem cells. Then, the random 
results of directed differentiation may be explained by imperfect approach of cell isolation. 
In fact, majority of protocols used is based rather on adhesion capacity of MSC than on 
specificity of a membrane marker not yet identified.            
At the first time, on the basis of morphological differences, the heterogeneity of MSC was 
brought up by Colter et al. (2000) which proposed three types of MSC. Two first, named RS-
1 and RS-2, characterized by a little size and absence or presence of granulations, were 
considered as self-renewal cells. The third type, distinguished by apparently bigger size, 
seemed corresponded to already partially differentiated (CSMm) cells (Colter et al., 2000). 
Thus, the authors hypothesized that RS-1 and RS-2 cells were progenitors of CSMm but 
since more quiescent state, RS-1 population appeared as precursor of RS-2 that 
differentiated to CSMm cells. In the proposed schema, RS-2 population would have had the 
capacity to maintain equilibrium of CSMm production by the ability to reprogramming 
towards the ground RS-1 state (Colter et al., 2000). In reality, the ulterior antigenic study of 
these three cellular populations that matching these morphological differences revealed yet 
more important cellular heterogeneity than initially supposed (Colter et al., 2001).    
2.2 Evidence of rabbit MSC heterogeneity 
The above data indicated the necessity to explore this proposed heterogeneity of MSC on the 
molecular level with particular insight into differences between clonal colonies which seems 
to be essential in elaboration of final approach of directed differentiation. Thus, we carried 
out the study having for objective the molecular characterization of colonies proliferating 
from individual CD45- mononuclear cells isolated from bone marrow of rabbit. This model 
was chosen for relative facility to obtain a biological material. This advantage being 
unfortunately associated with limited knowledge of rabbit genome, we have employed the 
Differential-Display Reverse Transcription-Polymerase Chain Reaction (DDRT-PCR) 
technique to analyze expressed respective mRNAs (Sturtevant, 2000). This approach resides 
in use of several non-specific primers able to hybridize with certain extracted mRNA during 
low temperature reaction (for more details see original paper of Sturtevant, 2000). In this 
way, the comparison of obtained patterns of mRNA in analyzed colonies showed 
differences in genes expression. The colonies were cultured separately after isolation of each 
clone proliferated from one cell on the surface delimited by cylinder (Figure 1A). After the 
harvest, the mRNA extract of each colony was analyzed with DDRT-PCR approach. In the 
figure 1B, we present the DDRT-PCR patterns of amplicons obtained after analyze of 14 
colonies with couple 1 of DDRT-PCR primers purchased from Seegen (Seoul, Korea). Thus, 
these patterns, despite a certain similitude, vary by five differentially expressed mRNAs 
marked by the arrows. These genes correspond to proteins implicated in different cellular 
functions as follows: 1 – TBC1D7- cellular growth and proliferation; 2 – Filamine – cell 
migration; 3 – Cystatine 10 – chondrogenesis; 4- LUC7-like – inhibition of myogenic 
differentiation; 5 – MTHFR – inhibition of intracellular methylation. Their expression seem 
to be convergent with expression of OCT-4 gene (Figure 1C) considering as a marker of non 
differentiated cellular state (Tondreau et al., 2005). 
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Fig. 1. Contribution to the hypothesis of MSC cells heterogeneity. A. Schematic 
representation of MSC clonal colonies development.  After delimitation of one cell in the 
cylinder space and its proliferation, young colony is displaced in Petri dish where continues 
to proliferate. Just before confluence, cells are harvested for extract of RNAs. B. Differential 
Display Reverse Transcription-Polymerase Chain Reaction (DDRT-PCR) gel containing the 
amplicons obtained from 14 colonies extracts. The arrows indicate sequenced bands 
corresponding to TBC1D7, Filamine, Cystatine 10, LUC7-like, MTHFR gens. See the text for 
more details. C. Histograms representing the expression of OCT-4 gen. The line visualizes 
the mean level of relative OCT-4 expression.       
It was interesting to observe, that in the medium LIF-free (Leukemia Induced Factor is 
employed in view to preserve non differentiated state during cell proliferation) the colonies 
were able spontaneously differentiated to muscle precursor cells with unequal capacities 
(Figure 2).  
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Fig. 2. Relative spontaneous expression of α-actin gene in studied colonies. The presence 
of actin was revealed by indirect immunocytochemistry where the presence of specific 
antibody was detected with horseradish peroxydase system.        
All these results clearly indicate that mononuclear CD45- cells, still considered as MSC, form 
a heterogenic population characterized by different non differentiated and committed state. 
Our results did not determine the definitive number of cellular clones but suggest that 
currently practiced isolation of MSC may conducted toward random results of directed 
differentiation.   
2.3 Toward a new hierarchy of bone marrow stem cells 
Our conclusion seems to be strongly supported by the similar results obtained by 
microarray analysis of human MSC (Mareddy et al., 2009; Tormin et al., 2009). In addition, 
common distribution of certain membranes markers as CD44, CD73, CD90 or CD105 
indicates that use of relative antibodies cannot be considered as discriminative tool for cell 
isolation. Thus, our results raised the question concerning hierarchy of organisation of bone 
marrow stem cells and place the observations previously published by groups of Verfaillie 
and Ratajczak at the special place. These key studies made mention of the very special cells 
named multipotent adult progenitor cells (MAPC) and very small embryonic-like cells 
(VSEL) respectively (Jiang et al., 2002; Kucia et al., 2006). Even if these results cannot be 
reproduced by other laboratories, MAPC possessing similar morphology to MSC are able 
generate mature cells characterizing by ecto-, meso- and endodermal features. This 
pluripotentiality, attesting their immature character, allows thinking that MAPC may be 
direct precursor of MSC as well as HSC (Jiang et al., 2002). Conceivably, this hypothesis may 
explain the random results of directed ex vivo MSC differentiation.  
In contrast, VSEL cells are a very small, morphologically similar to embryo cells which being 
probably attracted by the chemical gradient of SDF-1, colonize bone marrow during 
embryogenesis (Kucia et al., 2006). Amazingly, the grafts of VSEL in irradiated mice 
indicated that their weak number seems to be responsible for acceleration of senescence 
process which suggesting their participation in internal organs and tissues regeneration 
(Kucia et al., 2008). Convergently, the increased number of VSEL, expressing myogenic 
Nkx2.5 protein, detected in general circulation in patients suffering from cardiac ischemia 
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suggests the possibility of their implication in cardiovascular repair (Wojakowski et al., 
2009). In the case of definitive clinical confirmation, this observation may open extremely 
promising horizons of cellular therapy. Nevertheless, identification of these new cellular 
populations not responds to the question concerning the origin of MSC.                                    
In this context, our results support hypothesis that MSC cannot be considered as pluripotent 
stem cells having the potential to generate all cells naturally deriving from tree embryonic 
layers. In the Figure 3, we propose to attribute this role to MAPC and VSEL cells. There are 
two possibilities, either we observe a coexistence of three cellular populations or existence an 
ontogenetic hierarchy. In the first situation, each cellular type possesses the variable potency of 
differentiation: i) VSEL that of committed precursor, ii) MAPC would be pluripotent and iii) 
MCS just mesodermal. In the second situation, VSEL would be direct precursor of MAPC 
generating MSC among other. In this way, the apparition of all cellular populations in bone 
marrow would reflect an ontogenic hierarchy formed during embryogenesis where initial 
number of VSEL cells determines a capacity of hypothetic organ repair during adult life. It 
appears that however the reality may be, the strategy of preparation of graft from MSC should 
be revised taking into account the recent clinical trials lacking therapeutic effects as published 
recently (Menasche, 2011).  In fact, the clinical use of MSC is actually recognize for their 
immunomodulatory effects known in diminution of graft reject or graft versus host disease 
(Ringden et al., 2006; Ucceli et al., 2007; Le Blanc et al., 2008). In this way, two novel axes of 
fundamental research seem to be profiled: i) definite establishment of hierarchy of bone 
marrow cells in regard of MAPC and VSEL cells, ii) exploration of intracellular pathways in 
view to determine cellular fate during directed ex vivo differentiation.  
 
Fig. 3. Schematic representation of bone marrow stem cells hierarchy. A. Are we in the 
presence of three types of CSA which evolved separately according to the physiological 
regulation? B) Can one envisage a hierarchic ontogenic organization where VSEL cells 
would be pluripotent stem cells generating all bone marrow cells? 
3. Calcium signaling and fate of MSC 
3.1 Introduction 
The random results of ex vivo differentiation of MSC during preparation of autologous grafts 
indicate that promising potential may be revealed by the microenvironment of cellular 
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culture. This hypothesis seems to open a new area for proceedings of directed 
differentiation which may be based on modulation of activity of molecular targets of MSC. 
Given the dependence of phenotypical gene expression, self renewing, migration or 
proteolytical enzyme secretion on increase of cytosolic calcium concentration [Ca2+]c, 
pharmacological modulation of calcium signalling would represent a key to control cellular 
fate. The various membrane channels and ionic transporters having potential to modulate 
[Ca2+]c appears then as appropriate molecular targets. Recent reports indicate that MSC 
express several ionic membrane channels generating sodium (Na), calcium (Ca) and 
potassium (K) inward and outward currents characterized by molecular biology and patch-
clamp approaches (Li et al., 2005; Li et al., 2006; Deng et al., 2006; Kawano et al., 2003; 
Kawano et al., 2002; Heubach et al., 2004). Nevertheless, the capacity of these channels to 
modulate [Ca2+]c in MSC was not yet evaluated. Some data indicate that in human MSC, the 
[Ca2+]c may change upon cyclic oscillatory variations via a mechanism implicating inositol 
trisphosphate receptors (IP3Rs), store operating channels (SOCs), L-type voltage dependent 
calcium channels (L-VDCaCs) as well as Na+-Ca2+ exchangers (NCX) (Kawano et al., 2003; 
Kawano et al., 2002). We have recently shown that MSC express also several genes coding 
the proteins of transient receptor potential cation channel (TRPC1/2/4/6) family (Torossian 
et al., 2010) possessing a major role in cell proliferation as already documented in cancers (El 
Boustany et al., 2008). Over it, dependence of immature cell proliferation or myoblasts 
fusion (Lory et al., 2006) on activity of voltage dependent T-type calcium channel reinforces 
idea that pharmacological modulation of calcium signalling could reveal potential to 
improve efficiency of protocols employed in directed differentiation of adult stem cells.  
In the present study, using functional and molecular biology approaches, we pursued two 
major objectives: i) evaluation of efficiency of membrane voltage dependent ionic channels 
(VDCaC, VDNaC, VDKC) and transporters (Na/K-dependent ATPase and NCX) to 
modulate calcium homeostasis on the basis of kinetics of [Ca2+]c variations occasioned by 
selective activators and blockers, ii) demonstration that inactivation of chosen targets such 
T- or L- type VDCaC and TRPC1 reduced cellular proliferation and that high concentration 
of nifedipine activated neuroglial differentiation. 
3.2 Efficiency of molecular targets to modulate calcium homeostasis 
Figure N°4 illustrates that equilibrium state in single MSC is disturbed by modifications of 
the extracellular medium or by the presence of selective pharmacological agents which 
changing Ca2+, Na+ or K+ gradients induce the [Ca2+]c variations with different kinetics. The 
gathered histograms representing the areas under curves (AUC) were obtained from 
individual profiles whose averages are expressed in the Figures 4 and 5. The highest calcium 
mobilization was observed in the presence of depolarizing solution of KCl as well as 2-
diazo-4,6-dinitrophenol (DDNP) or bepridil, well known respective blockers of BKCa 
channels and NCX. Even if each product activated this increase by different mechanism, the 
obtained AUCs were very similar and corresponded to 5.5, 5.25 and 5.1 µM/L (Fig. 4). The 
depolarizing solution of KCl imposing membrane potential to value inferior to -30 mV 
activates low threshold VDCaCs as “L”- and/or “N”-type channels. Similar effect obtained 
with DDNP (Fig. 5D) revealed a high capacity of the BKCa channel inactivation to membrane 
depolarization subsequent to cytosolic K+ accumulation. The action of bepridil eliciting the 
reverse mode of NCX action is responsible for calcium influx which considered its proximity 
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with endoplasmic reticulum, induces intracellular calcium mobilization (Niggli et al., 1991). 
In the same way, figure 4 shows also that the action of Na/K-dependent ATPase having the 
capacity to modify sodium gradient induced cytosolic calcium increase by recruitment of 
NCX (Hilgemann et al., 1992). In contrast, the effect of other depolarizers as CaCl2 solution, 
tetraethylammonium (TEA) or veratridine (Fig 5B, 4C and Fig 6) appeared as less efficient. 
 
Fig. 4. Mean values of area under curves (AUC) of cytosolic calcium mobilization in 
rabbit mesenchymal (MSC) stem cells. KCl (25 mM) in the absence (n= 10) or in the 
presence of 10 µM nifedipine (  ; n= 15), CaCl2 (10 mM) in the absence (n= 14) or in the 
presence of 10 µM nifedipine (  ; n= 17), TEA (3 mM; n= 14), DDNP (10 µM; n= 6), 
veratridine alone (100 µM; n= 29) or in the presence of 1 µM TTX (  ; n= 22), ouabain (10 
µM; n= 6), Na-free (n= 11) and bepridil (100 µM; n= 17) were injected in the vicinity of MSC 
(***, p<0.001; **, p<0.01; *, p<0.1). The mean values (±SEM) of areas under curves were 
numerically integrated from individual microfluorimetric (Indo-1) recordings by trapeze 
method using Excel programme. Each recording represents the same number of points 
acquired every 250 ms by PC-assisted system developed by Notocord Systems (Paris, 
France). 
The type of VDCaCs was determined with nifedipine, a dihydropyridine derived L- type 
channel blocker and by RT-PCR experiments. The significantly reduced, but never totally 
abolished stimulatory effect of KCl and CaCl2 solutions on calcium mobilization in the 
presence of the blocker indicating the involvement of both nifedipine-sensitive and 
insensitive VDCaCs. RT-PCR convergent experiments, carried out with Cav1.2, Cav2.2 and 
Cav3.3 specific primers, confirmed expression of L-, N- and T-type of VDCaCs in MSC (Fig. 
4, boxes). L-type channels (Cav1.2 subunits) were already reported in human and rat MSC 
(Li et al., 2005; Li et al., 2006). In contrast, the existence of T channels in MSC are a matter of 
debate since contradictory reports concluding to the absence of Cav3.1 and Cav3.2 subunits 
(Li et al., 2005; Heubach et al., 2004) or to the presence of Cav3.2 whose functionality was 
however not determined (Kawano et al. 2002). The importance of expression of T channel in 
MSC is illustrated by observations in ESC where the sustained increase in [Ca2+]c is 
responsible for cell proliferation (Lory et al., 2006) or fusion of differentiated myoblasts 
(Bijlenga et al., 2000). The expression of N-type VDCaCs  in MSC is not surprising because 
its functionality in differentiating cells evolves through an expression pattern (Arnhold et 
al., 2000). Thus, during neuronal differentiation of ESC, transitory high expression of N-type 
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channel in initially apolar phenotype matched with cellular migration whereas its 
reappearance in differentiated neuron coincided, similarly to mature cells (Yokoyama et al., 
2005), with synaptogenesis and modification of the exocytose level (Jones et al., 1997). As 
MSC are known for their secretory and migratory activities, similar functionality may be 
expected. Consequently, calcium fluxes in MSC can be modified by opening of three types 
of VDCaCs which filling up the different cytosolic microdomains with calcium can 
separately control gene expression, cellular proliferation and migration or exocytosis (Lory 
et al., 2006; Yokoyama et al., 2005; Yang et al., 2006; Yoo et al., 2007). 
 
Fig. 5. Effects of modulation of calcium and potassium channels on [Ca2+]c in rabbit 
mesenchymal stem cells (MSC). The arrows indicate the pressure-ejected administration of 
depolarizing solution KCl (25 mM) (A), CaCl2 (10 mM) (B) and voltage or calcium 
dependent potassium channels blockers as TEA (3 mM) (C) and DDNP (10 µM) (D) in the 
vicinity of the cells. The right-placed boxes represent RT-PCR obtained amplicons of mRNA 
coding L, N, T-type voltage-dependent calcium channels (Cav1.2, Cav2.2 and Cav3.3 
subunits), voltage dependent (Kv1.4 subunit) and calcium dependent (BKCa) potassium 
channels. The curves represent a mean from 10 (A), 14 (B), 14 (C) and 6 (D) individual cell 
recordings. The spontaneous level of [Ca2+]c (100% basal level) was calculated for each 
experiment as the mean concentration during 30 s preceding the administration of ionic 
solutions or potassium channel blockers. 
Interestingly, the activation of T-type VDCaC in vivo appears to be directly dependent on a 
potassium gradient demonstrating the crucial role of K+ channels in the evolution of stem 
cell fate. This astute mechanism is based on cooperation between three types of ionic 
channels. Briefly, VDKC or/and CaDKC provoke transitory membrane hyperpolarization 
conducting to depolarizing potassium influx through delayed-rectifier potassium channel 
responsible for T-type VDCaC activation and [Ca2+]c increase. Such membrane 
hyperpolarization, detected in rat MSC (Deng et al., 2007) during progress of cell cycle from 
G(1) to S phase, seems to be dependet on the balance of expression between KCa3.1 and 
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delayed-rectifier (Kv1.2/Kv2.1) subunits which since their down-regulation with the specific 
RNAi appeared crucial for cell proliferation. Thus, the cooperation between IKCa and KDR 
channels that generate hyperpolarizing efflux and subsequently delaying influx of K+ may 
vary membrane polarity near the threshold value of T-type VDCaC activation.  
Amazingly, unlike the mechanism described above, we found pharmacological way to 
obtain ex vivo a similar effect on [Ca2+]c increase in MSC. Using functional and RT-PCR 
experiments, we observed that the blockage of Kv1.4 and BKCa channels (fig.4C, D) by TEA 
(51%; 32 of 63 cells) and DDNP (46%; 39 of 84 cells) induced [Ca2+]c-increase after VDCaC 
activation due to intracellular membrane depolarization triggered by cytosolic K+ 
accumulation. Further studies are needed to show whether such blockage of BKCa channel 
would stabilize cell proliferation and immaturity. 
The pharmacological activation of VDNaC represents another way to augment [Ca2+]c. 
Similarly to excitable cells like neurons or cardiocytes, the opening of VDCaCs in MSC 
results also from progressive membrane depolarization initiated by low threshold T-type 
VDCaC and/or VDNaC. In our experiments, veratridine (non-selective opener of VDNaCs) 
(Yang et al., 2006) started Na-induced depolarization which reaching activation threshold of 
VDCaCs   was responsible for increase of [Ca2+]c (84% given 54 of 64 cells). Not significant 
reduction of this effect by TTX, a VDNaCs blocker (t=0.38; 79% given 55 of 69 cells) (Fig. 5A) 
and identification of mRNA encoding Nav1.9 subunit (Fig 5A) indicated the expression of 
TTX-resistant VDNaCs in MSC. Noticeably, the type of VDNaC expression in MSC appears 
to be controversial. Using identical primer as Deng et al. (2006), we were unable to confirm 
their observation on expression of Nav1.1 subunit in rabbit MSC but we found relative 
transcript in extracts from rabbit nervous system which suggests non-expression of this 
subunit in our cultures. Divergent findings on the expression of VDNaC may also be noted 
in human MSC. While Heubach et al. (2004) failed to identify both TTX-resistant and TTX-
sensitive channels, Li et al. (2005) detected a functional TTX-sensitive inward current. These 
discrepancies may result from the different experimental protocols used. In our study, 
mononuclear cells were separated with CD45 antibody instead of their capacity to adhesion 
already reported (Li et al., 2005). Moreover, our mRNA samples were obtained at the final 
stage of the first passage contrary to the 4th or even the 8th as previously described (Li et al., 
2005; Deng et al., 2006). As expression of sodium channel unit in vivo changes throughout 
cellular maturation (Benn et al., 2001), these observed in vitro differences reveal modulation 
of gene expression by microenvironment. Nevertheless, the weak kinetics of calcium 
mobilization induced by veratridine seems indicate that VDNaCs did not appear as 
interesting target to modulate a fate of MSC. 
On the contrary, NCX having capacity to exchange cytosolic/extracellular Ca2+ for Na+ in 
normal or reverse mode (Niggli et al., 1991) within chemical gradient of both ionic 
populations, appears as powerful [Ca2+]c enhancer in MSC. As shown in Fig.6, Na-free 
medium (38% given 17 of 45 cells), bepridil (44% given 31 of 70 cells) or ouabain (62% given 
23 of 37 cells) led to transient increases in [Ca2+]c. The RT-PCR-detected expression of genes 
coding NCX and Na+/K+-ATPases (Figs. 6B, C) matched our functional observations. 
Similarly to other cellular models (Hilgemann et al., 1992), cytosolic overloading with 
sodium after ouabain-induced inactivation of Na+/K+-ATPase triggered a [Ca2+]c increase 
resulting from exchange of sodium for calcium during reverse mode action of NCX (Niggli 
et al., 1991). In human MSC, the NCX seems to take part in the induction of calcium 
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Fig. 6. Effects of modulation of voltage dependent sodium channels, ATPase Na+/K+ 
dependent and sodium-calcium exchanger activities on [Ca2+]c in rabbit mesenchymal 
stem cells (MSC). The arrows indicate the pressure-ejected administration of Veratridine 
(100 µM) (A), Ouabain (10 µM) (B), Na+-free medium (C) and Bepridil (100 µM) in the 
vicinity of MSC. The right-placed boxes represent the RT-PCR obtained amplicons of mRNA 
coding voltage-dependant sodium channel (Nav1.9 subunit) in MSC, Nav1.1 being detected 
only in brain rabbit extract,  ATPase Na-K dependend (B) and Na+-Ca2+ exchanger (NCX) 
(C). The curves represent a mean from 22 (A), 6 (B), 11 (C) and 17 (D) individual cell 
recordings. The spontaneous level of [Ca2+]c (100% basal level) was calculated for each 
experiment as the mean concentration during 30 s preceding the administration of ionic 
solutions or potassium channel blockers.  
oscillations (Kawano et al., 2003). In the present work, its activation induced a transient 
increase in [Ca2+]c followed by a slow basal calcium level recovery. It is like during early 
stage of cardiomyocyte differentiation of mouse ESC, where without modifying transient 
calcium variations, NCX enhanced the basal level of [Ca2+]c (Fu et al., 2006). This may 
indicate the crucial role of NCX in the stabilization of higher basal [Ca2+]c in immature cells 
where its activity may be improved by direct intracellular phosphorylation or by increase of 
Na-gradient during opening of VDNaC or Na+/K+-ATPase inhibition. 
3.3 Effects of VDCaCs inactivation on MSC cell culture 
Taken account of highest capacity to modify calcium homeostasis, VDCaCs was chosen as 
more appropriate target to evaluate pharmacological modulation of MSC fate. Another 
choice is related to TRPC1 protein which being largely expressed by rabbit MSC (Torossian 
et al., 2010) is known as one of essential factors managing calcium distribution during cancer 
cell proliferation (El Boustany et al., 2008; El Hiani et al., 2009). 
Then, the blockage of L- and T-type VDCaC pointed their implication in the control of 
cellular proliferation and differentiation. Mibefradil and nifedipine induced a dose-
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dependent decrease in cell numbers corresponding to 25 and 15 % of cells respectively at 10 
µM concentrations attaining very significant inhibition (65 and 50 %; p<0.005) when treated 
with 30 µM doses (Fig. 7). Similarly, inducing 45% inhibition of MSC proliferation, the 
specific siRNA demonstrated a major role of TRPC1 protein in this process. 
 
Fig. 7. Relative mesenchymal stem cells (MSC) proliferation in the presence of calcium 
channel blockers. MSC were cultured during 48 hours in the medium containing 
nifedipine, mibefradil (10 and 30 µM, both) or siRNA of TRPC1 (0.1 or 0.15 µM). The results 
represent the means (±SEM) from four independent experiments expressed as a percentage 
of proliferating cells. Each culture contained initially 20000 MSC and after 24h incubation 
period in expansion medium, the blockers at respective concentrations were administered in 
the plates. After 48h period of incubation the cells were fixed in acetic alcohol, stained with 
crystal Violet and extracted with acetic acid after drying. The optical density of extractions 
was evaluated using spectrophotometric measurement at 570 nm and compared to the 
standard range to obtain the number of cells. The relative effect of the drugs on cell 
proliferation was evaluated in comparison to non-treated cells (***, p<0.001; **, p<0.01; *, 
p<0.1). 
Noticeably, the presence of a higher concentration of nifedipine (100 µM) induced 
apparition of two types attached irregularly shaped cells. The first type, representing about 
85%, was characterized by expression of Glial Fibrillary Acidic Protein (GFAP) (Fig. 8B, D, 
F) whereas the second remained GFAP negative. This result may be particularly relevant in 
comparison to the control LIF-free culture where cells showed varied morphology and 
ability to spontaneously differentiate into myogenic precursor cells since relative to α-
smooth muscle actin staining (Fig. 8A) 
For the first time, we show that blockade of L-type channels in MSC may generate neural 
precursor cells already shown for their GFAP staining (Imura et al., 2003). We observed two 
kinds of GFAP+ cells corresponding to a low number of neural-like cells accompanied the 
large majority of staining cells displaying astrocyte-like morphology. The absence of GFAP 
staining in the LIF-free expansion medium and the disappearance of myogenic character 
after treatment with nifedipine, fully support the idea that pharmacological modulation of 
calcium homeostasis would reinforce strategy for directed differentiation of stem cells. 
These observations suggest that the reduction of higher and persistent [Ca2+]c appears like a 
turning point between proliferation and differentiation where favouring proliferation, the 
persistent calcium level avoids differentiation. 
0
25
50
75
100
10 30 10 30
C
e
ll 
g
ro
w
th
 (
%
)
Nif Mibef
TRPC1 
siRNA
0.1 (µM)0.15
*** ** *
www.intechopen.com
 
Autologous Grafts of Mesenchymal Stem Cells – Between Dream and Reality 493 
 
Fig. 8. Spontaneous myogenic and nifedipine induced GFAP+ cells derived from 
mesenchymal stem cells (MSC). (A) MSC stained with α-smooth muscle actin cultured in 
the LIF-free expansion medium. (B) Expression of GFAP in MSC cultured in the LIF-free 
expansion medium supplemented with 100 µM nifedipine. (C) Absence of GFAP expression 
in MSC cultured in the LIF-free expansion medium in the absence of nifedipine and counter 
staining with nuclear dye Hoechst. (D) Neural-like GFAP+ cells. (E,F) Morphological aspects 
of astrocyte-like cultured MSC in the LIF-free expansion medium supplemented with 100 
µM nifedipine (E, viable cell; F, GFAP+ fixed cell). Scale bars, 100 µm. 
The results obtained during prolonged exposition of MSC on both anticalcics seem to 
corroborate this hypothesis. As shown in the Fig. 9, the 10 µM doses were able introduce 
morphological modifications indicating the initiation of differentiation process. Cells 
growing in the presence of mibefradil (Fig. 9B) seem to display a more elongated and 
spindle shape while nifedipine favoured formation of cell extensions (Fig. 8C). Theirs action 
coincided with apparition of numerous vacuoles apparently more large and swollen in the 
presence of nifedipine (Fig. 8B, C). Since negative staining with oil red O, hematoxylin-
eosine, toluidine blue or periodic acid-Schiff (data not shown) these vacuoles did not contain 
lipids, glycoproteins nor mucopolysaccharides. Such formation, attributable to an 
intensification of autophagy process (Mizushima & Levy, 2010), was transiently observed 
during erythrocyte or lymphocyte differentiation (Kundu et al., 2008; Mortensen et al., 2010) 
and appeared crucial to adipogenesis (Baerga et al., 2009). According to information recently 
reported in human U-251 glioblastoma cells (Johnson et al., 2006) or maturating foetal 
hepatocytes (Matsunga et al., 2008), the mechanism of this process may be explain by not 
well understood dependency of initial stage of differentiation upon Ca-dependent PI3-
kinase activity. Interestingly, the siRNA-inactivation of TRPC1 expression did not modify 
cell morphology suggesting that unlike T and L type channels this protein is not implicated 
in MSC differentiation. 
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Fig. 9. Morphological modifications of mesenchymal stem cells (MSC) induced by 
calcium channel blockers. Culture of MSC in the LIF-free expansion medium in the absence 
(A) and in the presence of mibefradil, “T-type” (B) or nifedipine, “L-type” calcium channel 
blockers (C). Both blockers were employed at 10 µM concentration. Scale bar, 100 µm. 
3.4 Conclusion 
Taken together, our data demonstrated that pharmacological modulation of ionic carriers’ 
activity, as particularly T- and L-type VDCaC or TRPC1 protein, may reinforce the strategies 
employed ex vivo for directed differentiation of stem cells. Further studies should 
demonstrate whether pharmacologically induced modulation of [Ca2+]c in stem cells would 
maintain their immaturity or begin their differentiation.    
4. General discussion and perspectives 
The heterogeneity of MSC and their various commitments, as discussed above, perfectly 
explain why clinical application appears restraint their supposed pluripotentiality on 
immunological and mesenchymal capacity. In fact, not expressing II class MHC molecule, 
MSC are therefore not antigen-presenting cells and would be ignored by the host’s immune 
system (Tse et al., 2003; Krampera et al., 2003). By their constitutive secretory activity 
(Caplan, 2009), MSC have capacity to create microenvironment favourable to combat graft-
versus-host-disease (Koc et al., 2000) as well as attenuate inflammatory bowel symptoms in 
Crohn disease grafted patients (Caplan, 2009). Their aptitude for differentiate into 
osteoblasts was exploited in clinical trial for the treatment of osteogenesis imprfecta patients 
(Horowitz et al., 1999; 2002). One of very interesting work representing the regeneration of 
surgically amputated meniscus in goat by knee injection of MSC with hyaluronan delivery 
vehicle, provides perspective in the treatment of arthritis (Murphy et al., 2003). In contrast, 
use of MSC in view of cardiac post infracted reparation which seems to provide therapeutic 
improvement appeared to be not exerted by cardiomyocyte differentiation (Caplan, 2009). 
Convergently, the results of clinical trials realized with autologous MSC, HSC and 
mononuclear bone marrow cells (MNC) in about 1600 (Menasche, 2011) patients suffering 
from acute myocardial infarction, refractory angina or chronic heart failure did not give 
expected benefits indicating that heterogenic MNC of bone marrow, while remaining 
immunologically neutral, appear to be not therapeutically reliable to repair other than hard 
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tissues like bone or cartilage. Nevertheless, the existence of great variability in the 
functionality of MSC retrieved from patients indicating that pluripotent differentiation 
would be ascribed to more immature cells which are able generating MSC. Our study shows 
clearly that MSC should be considered as heterogeneous and composed by lineage-
committed cells that may be multipotent but certainly non pluripotent cells. In addition, 
parallelism between decrease in MSC number with age (Lennon et al., 1996) and 
acceleration of the senescence process in mouse grafted with a low number of VSEL cells 
(Kucia et al., 2008) strongly suggests that this role may be ascribed to VSEL cells which 
would represented this pluripotent cellular population. In this way, the unequal number of 
VSEL cells in isolated samples may explain the random results of ex vivo differentiation. It is 
therefore conceivable that specific isolation of this cell population represents the first 
problem to resolve. In fact, the number of data suggest that bone marrow may be considered 
as reserve of pluripotent cells but this property cannot be attributed to MSC.            
Our study of calcium signaling raises a second problem of directed differentiation 
representing by epigenetic reprogramming of gene expression which in an unpredictable 
manner would change the cellular fate. This conclusion is supported by divergence 
concerning the expression of VDCaCs and VDNaC in MSC. This inconvenience could be 
avoided in the cultures composed of a homogenous population of stem cells able 
reproducing stable microenvironment. Microenvironmental stability appears then as one of 
the more important conditions allowing prediction of cellular evolution and an objective 
comparison of the effects occasioned by experimentally introduced modifications. Our 
results indicated that pharmacological modulation of calcium homeostasis may influence 
cellular behavior seem open the perspectives for research of experimental protocols having 
potential to control the cell proliferation and differentiation. 
Taken together, it can be concluded that in view to realize a dream about autologous 
regenerative grafts it would be necessary to direct the basic research toward two major 
objectives: i) to find the strategy to facilely isolate pluripotent stem cells from the bone 
marrow and ii) to perfect protocols allowing control the evolution of cellular cultures.    
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